Skip to main content
Top
Published in: Rheumatology International 1/2005

01-01-2005 | Case Report

A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis

Authors: Mehmet Sayarlioglu, Nazan Topcu, Mustafa Harman, Unal Guntekin, Reha Erkoc

Published in: Rheumatology International | Issue 1/2005

Login to get access

Abstract

In patients with antiphospholipid syndrome (APS), thromboembolism and pulmonary hypertension are the most common pulmonary manifestations. Thrombotic obstruction at the level of the main and/or proximal pulmonary arteries is rare. We report a 40-year-old woman without any history of previous arterial and/or venous thrombosis who presented with severe dyspnea and was found to have pulmonary hypertension and positivity for anticardiolipin antibodies. Computed tomography revealed pulmonary truncus thrombosis extending to both right and left pulmonary arteries. The patient and her family refused surgical treatment. She had a prolonged hospital course, was unresponsive to thrombolytic, anticoagulant, antiplatelet, and immunosuppressive treatments, and died of right ventricle and respiratory failure 5 weeks later. This is the first reported case with thrombosis of pulmonary truncus and main pulmonary arteries concurrent with APS.
Literature
1.
go back to reference Greaves M, Cohen H, MacHin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109:704–715CrossRefPubMed Greaves M, Cohen H, MacHin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109:704–715CrossRefPubMed
2.
go back to reference Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I et al, European Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027CrossRefPubMed Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I et al, European Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027CrossRefPubMed
3.
go back to reference Asherson RA, Cervera R (1995) Review: antiphospholipid antibodies and the lung. J Rheumatol 22:62–66PubMed Asherson RA, Cervera R (1995) Review: antiphospholipid antibodies and the lung. J Rheumatol 22:62–66PubMed
4.
go back to reference Piette JC, Hunt BJ (2000) Pulmonary hypertension and antiphospholipid antibodies. In: Khamashta MA (ed) Hughes syndrome. Antiphospholipid syndrome. Springer, London, pp 96–104 Piette JC, Hunt BJ (2000) Pulmonary hypertension and antiphospholipid antibodies. In: Khamashta MA (ed) Hughes syndrome. Antiphospholipid syndrome. Springer, London, pp 96–104
5.
go back to reference Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 96:3–9CrossRefPubMed Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 96:3–9CrossRefPubMed
6.
go back to reference Amigo MC, Khamashta MA, Hughes GR (1998) Antiphospholipid syndrome in SLE. Baillieres Clin Rheumatol 12:477–493PubMed Amigo MC, Khamashta MA, Hughes GR (1998) Antiphospholipid syndrome in SLE. Baillieres Clin Rheumatol 12:477–493PubMed
7.
go back to reference Ando M, Takamoto S, Okita Y, Matsukawa R, Nakanishi N, Kyotani S, Satoh T (1998) Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann Thorac Surg 66:1919–1924CrossRefPubMed Ando M, Takamoto S, Okita Y, Matsukawa R, Nakanishi N, Kyotani S, Satoh T (1998) Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann Thorac Surg 66:1919–1924CrossRefPubMed
8.
go back to reference Luchi ME, Asherson RA, Lahita RG (1992) Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 35:700–705PubMed Luchi ME, Asherson RA, Lahita RG (1992) Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 35:700–705PubMed
9.
go back to reference Cucurull E, Ordi Ros J, Murtra M, Mellibovsky L, Orriols R, Vilardell M (1996) Pulmonary thromboendarterectomy in a patient with primary antiphospholipid syndrome. Med Clin (Barc) 106:498–500 Cucurull E, Ordi Ros J, Murtra M, Mellibovsky L, Orriols R, Vilardell M (1996) Pulmonary thromboendarterectomy in a patient with primary antiphospholipid syndrome. Med Clin (Barc) 106:498–500
10.
go back to reference Sandoval J, Amigo MC, Barragan R, Izaguirre R, Reyes PA, Martinez-Guerra ML, Palomar A, Gomez A, Garcia-Torres R (1996) Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy. J Rheumatol 23:772–775PubMed Sandoval J, Amigo MC, Barragan R, Izaguirre R, Reyes PA, Martinez-Guerra ML, Palomar A, Gomez A, Garcia-Torres R (1996) Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy. J Rheumatol 23:772–775PubMed
11.
go back to reference Nakagawa Y, Masuda M, Shiihara H, Tsuruta Y, Abe H, Miura M, Tanaka H (1992) Successful pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension associated with anticardiolipin antibodies: report of a case. Surg Today 22:548–552PubMed Nakagawa Y, Masuda M, Shiihara H, Tsuruta Y, Abe H, Miura M, Tanaka H (1992) Successful pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension associated with anticardiolipin antibodies: report of a case. Surg Today 22:548–552PubMed
12.
go back to reference Nakajima T, Ando H, Ueno Y, Umadome H, Takahashi Y, Okano Y, Takamoto S (1997) Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Jpn Circ J 61:958–964CrossRefPubMed Nakajima T, Ando H, Ueno Y, Umadome H, Takahashi Y, Okano Y, Takamoto S (1997) Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Jpn Circ J 61:958–964CrossRefPubMed
13.
go back to reference Hartz RS, Byrne JG, Levitsky S, Park J, Rich S (1996) Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg 62:1255–1259CrossRefPubMed Hartz RS, Byrne JG, Levitsky S, Park J, Rich S (1996) Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg 62:1255–1259CrossRefPubMed
14.
15.
go back to reference Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, Lim K, Munoz-Rodriguez FJ, Levy RA, Boue F et al (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195–207 Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, Lim K, Munoz-Rodriguez FJ, Levy RA, Boue F et al (1998) Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195–207
Metadata
Title
A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis
Authors
Mehmet Sayarlioglu
Nazan Topcu
Mustafa Harman
Unal Guntekin
Reha Erkoc
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0458-9

Other articles of this Issue 1/2005

Rheumatology International 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.